IDPH Idec Pharmaceuticals (MM)

Standard & Poor's Announces Changes to S&P U.S. Indices NEW YORK, Nov. 6 /PRNewswire/ -- Standard & Poor's will make the following changes in the S&P 500, S&P MidCap 400 and S&P SmallCap 600 Indices after the close of trading on Wednesday, November 12, 2003: * S&P MidCap 400 constituent IDEC Pharmaceuticals Corp. (NASDAQ:IDPH) is acquiring S&P 500 constituent Biogen Inc. (NASDAQ:BGEN) in a transaction anticipated to close on or about November 12. Consequently the newly created company, BIOGEN IDEC Inc. (NASDAQ:BIIB), will replace Biogen Inc. in the S&P 500, S&P SmallCap 600 constituent Raymond James Financial Inc. (NYSE:RJF) will replace IDEC Pharmaceuticals in the S&P MidCap 400, and United Surgical Partners International Inc. (NASDAQ:USPI) will replace Raymond James Financial in the S&P SmallCap 600 Index. The Biogen-IDEC merger is still contingent upon shareholder approval. Standard & Poor's will monitor this transaction, and post any relevant updates on its website: http://www.standardandpoors.com/. BIOGEN IDEC is a global biotechnology company, featuring products and capabilities in cancer and autoimmune diseases. The company, headquartered in Cambridge, MA, will be added to the S&P 500 GICS (Global Industry Classification Standard) Biotechnology sub-industry. Raymond James Financial is engaged principally in the securities brokerage business, and also provides investment management services for retail and institutional clients. The company, headquartered in St. Petersburg, FL, will be added to the S&P MidCap 400 GICS Investment Banking & Brokerage sub- industry. United Surgical Partners Int'l. owns and operates short-stay surgical facilities, including surgery centers and private surgical hospitals, in the United States, Spain and England. The company, headquartered in Addison, TX, will be added to the S&P SmallCap 600 GICS Health Care Facilities sub- industry. Following is a summary of the changes: S&P 500 INDEX - November 12, 2003 COMPANY GICS ECONOMIC SECTOR GICS SUB-INDUSTRY ADDED BIOGEN IDEC Health Care Biotechnology DELETED Biogen Inc. Health Care Biotechnology S&P MIDCAP 400 INDEX - November 12, 2003 COMPANY GICS ECONOMIC SECTOR GICS SUB-INDUSTRY ADDED Raymond James Financials Investment Banking Financial & Brokerage DELETED IDEC Pharmaceuticals Health Care Biotechnology S&P SMALLCAP 600 INDEX - November 12, 2003 COMPANY GICS ECONOMIC SECTOR GICS SUB-INDUSTRY ADDED United Surgical Health Care Health Care Partners Int'l Facilities DELETED Raymond James Financials Investment Banking Financial & Brokerage Additions to and deletions from an S&P equity index do not in any way reflect an opinion on the investment merits of the companies concerned. Standard & Poor's, a division of The McGraw-Hill Companies (NYSE:MHP), is the world's foremost provider of independent credit ratings, indices, risk evaluation, investment research, data and valuations. With 5000 employees located in 20 countries, Standard & Poor's is an essential part of the world's financial infrastructure, and has played a leading role for more than 140 years in providing investors with the independent benchmarks they need to feel more confident about their investment and financial decisions. For more information, visit http://www.standardandpoors.com/. Founded in 1888, The McGraw-Hill Companies is a global information services provider meeting worldwide needs in the financial services, education and business information markets through leading brands such as Standard & Poor's, BusinessWeek and McGraw-Hill Education. The Corporation has more than 320 offices in 34 countries. Sales in 2002 were $4.8 billion. Additional information is available at http://www.mcgraw-hill.com/. DATASOURCE: Standard & Poor's CONTACT: David Blitzer Managing Director, Quantitative Services (212) 438-3907 Web site: http://www.standardandpoors.com/ http://www.mcgraw-hill.com/

Copyright